Melancholic Depression: Clinical Features, Diagnosis, and Treatment Challenges

Melancholic depression is a specifier for major depressive disorder (MDD) characterized by profound anhedonia, psychomotor disturbance, and distinct vegetative symptoms. It carries high suicide risk and often requires aggressive treatment.

Core Diagnostic Features (DSM-5 Melancholic Specifier)

• Anhedonia: Near-total loss of pleasure in all/almost all activities.
• Lack of mood reactivity: Mood does not brighten even to positive events.
• Distinct quality of depressed mood: Described as "despair," "emptiness," different from grief.
• Diurnal variation: Worse in morning.
• Early morning awakening: ≥2 hours before usual.
• Psychomotor agitation or retardation (observable).
• Significant anorexia/weight loss.
• Excessive/inappropriate guilt.

Associated Features

• Psychotic features (mood-congruent delusions, hallucinations) in severe cases.
• Cognitive impairment (pseudodementia).
• Hyperarousal HPA axis (elevated cortisol, dexamethasone non-suppression).

Treatment

• First-line: Antidepressants with noradrenergic/dopaminergic activity (SNRIs, TCAs, MAOIs) may have advantage over SSRIs.
• ECT (electroconvulsive therapy): Gold standard for severe, psychotic, or treatment-resistant melancholia; rapid response.
• Augmentation: Lithium, atypical antipsychotics, thyroid hormone.
• Psychotherapy: CBT, IPT as adjunct; less effective alone in severe melancholia.

Prognosis

Episodic but recurrent. High remission rates with ECT; medication resistance more common. Maintenance treatment often needed.

Urgent: Any suicidal ideation requires immediate safety assessment and intervention.